INSIGHTS ON DRUG DEVELOPMENT

• From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined

  Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.

• How Recent Trends Impact Bringing Your Molecule To Market

  With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.

• Innovative Strategies For Residual DNA And Viral Titre Quantitation

  Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.

• Navigating The Regulatory Space To Biosimilar Approval

  The biosimilar patent cliff is reshaping pharma, creating unprecedented opportunities for biotech and CDMOs. Explore expert regulatory support that can help you navigate this shift with confidence.

• An Unparalleled Window Into IBD Immune Response

  8/7/2024

  Discover how Organ-Chips provide an unparalleled view into the human immune response to IBD and allow researchers to accurately model the intricacies of immune cell recruitment.

• Enabling Quality By Design

  9/8/2025

  Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

• R&D Excellence at Asymchem's UK Facility

  3/12/2026

  Dave Henderson outlines R&D excellence at a UK facility, highlighting integrated labs, advanced experimentation, expert teams, and seamless progression from discovery through scale-up and manufacturing.

• Screening For Amorphous Drug Substance

  5/6/2026

  Incorporate amorphous form screening early in development to unlock solubility advantages, improve bioavailability, and accelerate your path to market.

• Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form

  3/4/2025

  Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.